<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date>05/01/2023</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Jankowski</forename><surname>Maciej</surname></persName>
							<affiliation key="aff0">
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Beatrice</forename><surname>Mme</surname></persName>
							<affiliation key="aff0">
							</affiliation>
						</author>
						<author>
							<persName><surname>Barletti</surname></persName>
							<affiliation key="aff0">
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Institut</forename><surname>Laue-Langevin</surname></persName>
							<affiliation key="aff0">
							</affiliation>
							<affiliation key="aff0">
							</affiliation>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Marco</forename><surname>Maccarini</surname></persName>
							<affiliation key="aff0">
							</affiliation>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Giovanna</forename><surname>Fragneto</surname></persName>
							<affiliation key="aff0">
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mr</forename><surname>Jean-Pierre Alcaraz</surname></persName>
							<affiliation key="aff0">
							</affiliation>
						</author>
						<title level="a" type="main">Names and affiliations of applicants (* indicates experimentalists)</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published">05/01/2023</date>
						</imprint>
					</monogr>
					<idno type="MD5">74B7AF9C31BB64CE8E24CEF9723A1892</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-05-23T15:25+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">unknown</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=1, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>LS-3092</keywords>
			</textClass>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experiment title:</head><p>Nanostructural characterisation of protein interactions with lipid bilayer membranes: basis for biosensor development </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Report:</head><p>The aim of the project is to study at nanostructural level the interaction between the biomarker, soluble Vascular-Endothelial cadherin (sVE), and biologically relevant lipid bilayer membranes using X-ray scattering techniques, and particurlarly to identify how different lipids can affect this interaction to build a potential biosensor, in which this interaction is enhaced, that is aimed for early detection of scarce biomarkers in blood samples. These fundamental results will better elucidate the mechanism of interaction between protein and lipids and will set the basis for the development of biosensors aimed to optimise the sensitivity and reliability of biosensing techniques for biomarkers of tumours.</p><p>In this context it is important to understand the effect of glycosylation since the majority of biomarkers of tumours are glycosylated. As reported in a previous related study <ref type="bibr" target="#b0">[1]</ref>, the glycosylated state of proteins leads to easy formation of protein/lipid complexes with either HDL or LDL particles. To discriminate the effect of glycosylation we tested two different proteins, soluble Vascular-Endothelial cadherin (sVE) and Bovine Serum Albumin (BSA), with supported lipid bilayers (SLBs) of different lipid compositions. sVE is the glycosylated extracellular domain of the Vascular-Endothelial cadherin and is cleaved from endothelial cells following inflammation or infection, leading to loss of the endothelium's barrier function <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4]</ref>, whereas BSA is a nonglycosylated protein belonging to the serum albumins family. The experiment at ID10 was successfully performed. To study protein/lipid bilayer interactions, we performed X-ray scattering measurements (XRR and GID) on three different lipid bilayers with and without the presence of proteins to obtain information on structural changes, such as thickness, roughness and hydration as a function of lipid mixtures, and the amount and average localisation of proteins. In particular, results on three different lipid compositions of SLBs (pure POPC, POPC/DOTAP 70:30 and POPC/SM/CHOL 60:30:10) with two different proteins (sVE and BSA) were obtained.</p><p>For each system we acquired various scans in different positions of the empty silicon substrate, the bilayer and the bilayer after the injection of the protein. The kinetic of absorption/insertion of proteins was also studied.</p><p>Examples of reduced and normalised reflectivity curves are reported in Figure <ref type="figure" target="#fig_1">1</ref>. The results show different effects on protein interaction with different lipids in the membrane model. A similar interaction behaviour is observed for sVE and BSA with the pure POPC bilayer. A greater interaction for both proteins is highlighted with the SLB of composition POPC/DOTAP 70:30. The presence of the cationic lipid in the mixture favoures the interaction with proteins which are negatively charged at physiological pH of the working buffer. In addition, a bilayer with composition POPC/SM/CHOL 50:25:25 was tested in the presence of BSA. GID scans of this last cited system show interesting results demostrating the presence of different lateral distribution depending on the position.</p><p>Data analysis is in progress and is performed using both the Motofit plug-in for Igor Pro and the software Refnx to check the consistency of results between programs. The sample systems will be modelled as a series of homogeneous slabs, each slab will be described by the four parameters thickness, SLD, roughness and solvent percentage or hydration in the layer.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Complementary measurements</head><p>Complementary measurements with sVE on the last lipid composition tested (POPC/SM/CHOL 50:25:25) are still necessary.</p><p>To further discriminate the effect of glycosylation on the interaction, we are willing to perform new synchrotron XRR experiments using different glycosylated proteins, such as alpha-fetoprotein (biomarker for liver cancer) and glycosylated BSA. The interaction with SLBs will be characterised using the same parameters and lipid compositions tested for the previous proteins. The results with the four different proteins will be compared and elucidation on the effect of glycosylation and impact of different lipids will be highlighted.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Names and affiliations of applicants(* indicates experimentalists): Mme Beatrice Barletti* (Institut Laue-Langevin) Dr Marco Maccarini* (CNRS, TIMC) Dr Giovanna Fragneto (Institut Laue-Langevin) Mr. Jean-pierre Alcaraz (TIMC) Professor Donald Martin (TIMC)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 1 .</head><label>1</label><figDesc>Figure 1. (a) Reflectivity curve for the pure POPC bilayer (light blue line) and with the presence of sVE (purple line) or BSA (yellow line) in PBS. (b) Reflectivity curve for the POPC/DOTAP 70:30 bilayer (light blue line) and with the presence of sVE (purple line) or BSA (yellow line) in PBS. (c) Reflectivity curve for the POPC/SM/CHOL 60:30:10 bilayer (light blue line) and with the presence of sVE (purple line) or BSA (yellow line) in PBS.</figDesc><graphic coords="4,34.00,84.25,511.61,143.50" type="bitmap" /></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A Biomimetic Lipid Membrane Device Reveals the Interaction of Cancer Biomarkers with Human Serum Lipidic Moieties</title>
		<author>
			<persName><forename type="first">Abir</forename><surname>Khalil‐mgharbel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Helena</forename><surname>Polena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Paul</forename><forename type="middle">K</forename><surname>Dembélé</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Md.</forename><forename type="middle">Mehadi</forename><surname>Hasan Sohag</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jean‐pierre</forename><surname>Alcaraz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Donald</forename><forename type="middle">K</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Isabelle</forename><surname>Vilgrain</surname></persName>
		</author>
		<idno type="DOI">10.1002/biot.201800463</idno>
	</analytic>
	<monogr>
		<title level="j">Biotechnology Journal</title>
		<title level="j" type="abbrev">Biotechnology Journal</title>
		<idno type="ISSN">1860-6768</idno>
		<idno type="ISSNe">1860-7314</idno>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">1800463</biblScope>
			<date type="published" when="2018-12">2018</date>
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">A. Khalil-Mgharbel, H. Polena, P.K. Dembélé, Md. M. Hasan Sohag, J-P Alcaraz, D.K. Martin, and I. Vilgrain, A Biomimetic Lipid Membrane Device Reveals the Interaction of Cancer Biomarkers with Human Serum Lipidic Moieties, Biotechnology Journal (2018), 13:1800463.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunction</title>
		<author>
			<persName><forename type="first">Sophie</forename><surname>Blaise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Helena</forename><surname>Polena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Isabelle</forename><surname>Vilgrain</surname></persName>
		</author>
		<idno type="DOI">10.1177/1358863x15591201</idno>
	</analytic>
	<monogr>
		<title level="j">Vascular Medicine</title>
		<title level="j" type="abbrev">Vasc Med</title>
		<idno type="ISSN">1358-863X</idno>
		<idno type="ISSNe">1477-0377</idno>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="557" to="565" />
			<date type="published" when="2015-06-30">2015</date>
			<publisher>SAGE Publications</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Blaise, S., Polena, H. &amp; Vilgrain, I. Soluble vascular endothelial-cadherin and auto-antibodies to human vascular endothelial-cadherin in human diseases: Two new biomarkers of endothelial dysfunction. Vasc. Med. 20, 557-65 (2015), DOI: 10.1177/1358863X15591201</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Flemming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Burkard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Renschler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Vielmuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Meir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wunder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C-T</forename><surname>Germer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Spindler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Waschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Schlegel</surname></persName>
		</author>
		<idno type="DOI">10.1093/cvr/cvv144</idno>
	</analytic>
	<monogr>
		<title level="j">Cardiovascular Research</title>
		<title level="j" type="abbrev">Cardiovascular Research</title>
		<idno type="ISSN">0008-6363</idno>
		<idno type="ISSNe">1755-3245</idno>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="32" to="44" />
			<date type="published" when="2015-05-14">2015</date>
			<publisher>Oxford University Press (OUP)</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">Flemming, S. et al. Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis. Cardiovasc. Res. 107, 32-44 (2015), DOI: 10.1093/cvr/cvv144</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: Towards a candidate biomarker</title>
		<author>
			<persName><forename type="first">I</forename><surname>Vilgrain</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone0080056</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vilgrain, I. et al. Evidence for post-translational processing of vascular endothelial (VE)-cadherin in brain tumors: Towards a candidate biomarker. PLoS One 8, (2013), DOI:10.1371/journal.pone0080056</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
